Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,85 GBX | 0,00% | 0,00% | +14,00% |
Vakgebied
Verkoop per activiteit
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 73 | 100,0 % | 60 | 100,0 % | -18,11% |
Verkoop per regio
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Germany
53,0
%
| 43 | 59,0 % | 32 | 53,0 % | -26,44% |
Spain
16,0
%
| 9 | 12,0 % | 10 | 16,0 % | +9,18% |
Austria
8,0
%
| 5 | 7,0 % | 5 | 8,0 % | -6,42% |
Netherlands
7,0
%
| 4 | 6,0 % | 4 | 7,0 % | -4,47% |
Switzerland
5,0
%
| 3 | 4,0 % | 3 | 5,0 % | +2,36% |
Italy
5,0
%
| 4 | 5,0 % | 3 | 5,0 % | -18,11% |
United Kingdom
3,0
%
| 1 | 2,0 % | 2 | 3,0 % | +22,83% |
Czech and Slovak
2,0
%
| 2 | 3,0 % | 1 | 2,0 % | -45,41% |
Other
1,0
%
| 1 | 2,0 % | 1 | 1,0 % | -59,06% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Manuel Llobet
CEO | Chief Executive Officer | 60 | 01-07-09 |
Shaun Furlong
DFI | Director of Finance/CFO | - | 01-04-22 |
Murray Skinner
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-04 |
Matthias Kramer
PRN | Corporate Officer/Principal | - | 01-05-13 |
Sue Baker
HRO | Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 67 | 06-06-17 | |
Peter Jensen
CHM | Chairman | 73 | 01-10-10 |
Anthony Parker
BRD | Director/Board Member | - | 06-12-22 |
Manuel Llobet
CEO | Chief Executive Officer | 60 | 01-07-09 |
Zhe Qing Shen
BRD | Director/Board Member | 45 | 06-12-22 |
Director/Board Member | 56 | 27-10-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 4 766 439 938 | 323 443 304 ( 6,786 %) | 0 | 6,786 % |
Bedrijfsgegevens
Allergy Therapeutics Plc
Dominion Way
BN14 8SA, Worthing
+44 1903 844 700
http://www.allergytherapeutics.comSector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,00% | 169 mln. | |
-3,30% | 102 mld. | |
+1,79% | 96,07 mld. | |
-2,07% | 21,66 mld. | |
-18,35% | 20,77 mld. | |
-8,45% | 18,53 mld. | |
-40,31% | 16,91 mld. | |
-26,84% | 13,79 mld. | |
+0,59% | 13,33 mld. | |
+20,86% | 10,94 mld. |